A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Project: Research

Project Details

StatusActive
Effective start/end date27/03/24 → 26/03/26

Keywords

  • Clinical trial
  • 77242113PSO3004